HPV Testing And Vaccination Knowledge And Uptake Among Final-Year Medical Students İn Central Anatolia: A Cross-Sectional Study

MELİKE GEYİK BAYMAN, Ümmügülsüm Esenkaya , Özlem ARIK

  • Ümmügülsüm Esenkaya: SAĞLIK BİLİMLERİ ÜNİVERSİTESİ KONYA ŞEHİR HASTANESİ
  • Özlem ARIK: Necmettin Erbakan University Faculty of Medicine
  • Year : 2026
  • Vol : 42
  • Issue : 3
  •  Page : 316-321
Objective: This study aimed to evaluate knowledge of human papillomavirus (HPV ), HPV testing, and HPV vaccination among final-year medical students in Central 
Anatolia and to determine HPV vaccination uptake.
Materials and Methods: We conducted this cross-sectional descriptive study between March and June 2025. After ethics committee approval, we distributed an online 
questionnaire to intern doctors from eight medical faculties in Konya, Ankara, Kayseri, Aksaray, and Karaman in the Central Anatolia Region. A total of 384 interns 
who voluntarily participated and completed the questionnaire were included in the study. Data were collected using an online survey comprising sociodemographic 
characteristics and the 33-item Turkish-validated Human Papillomavirus Knowledge Scale (HPV-KS). Statistical analyses were performed using SPSS version 31, and 
group comparisons were conducted using the Mann–Whitney U test. A p value of <0.05 was considered statistically significant.
Results: Among the 384 intern doctors included in the study, only 2.1% had received the HPV vaccine. The mean HPV knowledge score was 24.64±3.92. Among the 
subdomains, general HPV knowledge was highest, whereas knowledge regarding the protective effects of HPV vaccines was lowest. Notable gaps were identified in 
knowledge related to HPV testing and vaccination. No significant associations were observed between sociodemographic or behavioural characteristics and HPV 
knowledge levels (p>0.05).
Conclusion: Final-year medical students demonstrated significant deficiencies in HPV-related knowledge and very low vaccination uptake. These findings suggest 
that current medical education may be insufficient in terms of preventive medicine. Strengthening HPV-related education may improve future patient counselling 
and contribute to increasing vaccination rates.
Cite this Article As : Geyik Bayman M, Esenkaya U, Arik O. HPV Testing and Vaccination Knowledge and Uptake Among Final-Year Medical Students İn Central Anatolia: A Cross-Sectional Study. Selcuk Med J 2026;42(3): 316-321

Download Citation: Endnote/Zotero/Mendeley (RIS) RIS File

Download Citation: BibTeX BibTeX File

Conflict of interest : The authors declare that they have no conflict of interest.
This article is published under the CC BY-NC 4.0 license.
Selcuk Medical Journal
2026, Vol. 42 (3)
ISSN: 1017-6616
E-ISSN: 2149-8059
Received : , Accepted : , Published Online :

References

  1. 1. Akinnibosun O, Abakpa OG, Ujoh AJ, et al. Knowledge, attitudes and practices among women of reproductive age on human papillomavirus infection, cervical cancer and vaccination in Otukpo, Nigeria. Ethiop J Health Sci. 2024;34(1):15-26. doi: 10.4314/ejhs.v34i1.3.
  2. 2. de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8(2):e180-90. doi: 10.1016/S2214-109X(19)30488-7.
  3. 3. de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664-70. doi: 10.1002/ijc.30716.
  4. 4. Alemany L, Saunier M, Alvarado-Cabrero I, et al. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide. Int J Cancer. 2015;136(1):98-107. doi: 10.1002/ijc.28963.
  5. 5. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191-203. doi: 10.1016/S2214-109X(19)30482-6.
  6. 6. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention. Genital HPV infection - CDC fact sheet. 2017. Available from: https://stacks.cdc.gov/view/cdc/130186.
  7. 7. Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012;30(Suppl 5):F55-70. doi: 10.1016/j.vaccine.2012.06.083.
  8. 8. Demir Bozkurt F, Özdemir S. Validity and reliability of a Turkish version of the human papillomavirus knowledge scale: a methodological study. J Turk Ger Gynecol Assoc. 2023;24(3):177-86. doi: 10.4274/jtgga.galenos.2023.2022-10-9.
  9. 9. Mekonnen BA, Anagaw YK, Kassahun BA, et al. Evaluation of female university students’ knowledge, attitudes, and practices toward human papillomavirus infection and vaccination: a multicenter cross-sectional study. BMC Womens Health. 2024;24(1):437. doi: 10.1186/s12905-024-03279-6.
  10. 10. Wang H, Liu F, Zhang H, et al. Influential factors and willingness to advocate for HPV vaccination among male nursing interns in China. BMC Nurs. 2024;23(1):628. doi: 10.1186/s12912-024-02324-x.
  11. 11. Afacan Yıldırım E, Kızık TN. Human papillomavirus (HPV) awareness and vaccine hesitancy among medical students: a cross-sectional study on knowledge, stigma, and preventive behavior. Turk J Dermatol. 2025;19(3):118-25. doi: 10.4274/tjd.galenos.2025.05706.
  12. 12. Du EY, Adjei Boakye E, Taylor DB, et al. Medical students' knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer. Hum Vaccin Immunother. 2022;18(6):2109892. doi: 10.1080/21645515.2022.2109892.
  13. 13. López N, Garcés-Sánchez M, Panizo MB, et al. HPV knowledge and vaccine acceptance among European adolescents and their parents: a systematic literature review. Public Health Rev. 2020;41:10. doi: 10.1186/s40985-020-00126-5.
  14. 14. Ozdemir CY, Marangoz B, Cicekli N, et al. HPV vaccine awareness and vaccination status among women of reproductive age in Türkiye: a cross-sectional study. Hum Vaccin Immunother. 2025;21(1):2586826. doi: 10.1080/21645515.2025.2586826.
  15. 15. Forster AS, Marlow LAV, Wardle J, et al. Interest in having HPV vaccination among adolescent boys in England. Vaccine. 2012;30(30):4505-10. doi: 10.1016/j.vaccine.2012.04.066.